Pagh A, Grau C, Overgaard J. Failure pattern and salvage treatment after radical treatment of head and neck cancer. Acta Oncol. 2016;55(5):625–32.

Article  PubMed  Google Scholar 

Due AK, Vogelius IR, Aznar MC, Bentzen SM, Berthelsen AK, Korreman SS, Loft A, Kristensen CA, Specht L. Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake. Radiother Oncol. 2014;111(3):360–5.

Article  PubMed  PubMed Central  Google Scholar 

Corvo R. Evidence-based radiation oncology in head and neck squamous cell carcinoma. Radiother Oncol. 2007;85(1):156–70.

Article  PubMed  Google Scholar 

Antognoni P, Corvo R, Zerini D, Orecchia R. Altered fractionation radiotherapy in head and neck cancer: clinical issues and pitfalls of “evidence-based medicine.” Tumori. 2005;91(1):30–9.

Article  PubMed  Google Scholar 

Leclerc M, Maingon P, Hamoir M, Dalban C, Calais G, Nuyts S, Serre A, Gregoire V. A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach. Radiother Oncol. 2013;106(3):333–40.

Article  PubMed  Google Scholar 

Gebre-Medhin M, Brun E, Engstrom P, Haugen Cange H, Hammarstedt-Nordenvall L, Reizenstein J, Nyman J, Abel E, Friesland S, Sjodin H, et al. ARTSCAN III: a randomized phase iii study comparing chemoradiotherapy with cisplatin versus cetuximab in patients with locoregionally advanced head and neck squamous cell cancer. J Clin Oncol. 2021;39(1):38–47.

Article  CAS  PubMed  Google Scholar 

Atwell D, Elks J, Cahill K, Hearn N, Vignarajah D, Lagopoulos J, Min M. A review of modern radiation therapy dose escalation in locally advanced head and neck cancer. Clin Oncol. 2020;32(5):330–41.

Article  CAS  Google Scholar 

Welz S, Monnich D, Pfannenberg C, Nikolaou K, Reimold M, La Fougere C, Reischl G, Mauz PS, Paulsen F, Alber M, et al. Prognostic value of dynamic hypoxia PET in head and neck cancer: Results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trial. Radiother Oncol. 2017;124(3):526–32.

Article  PubMed  Google Scholar 

Caudell JJ, Gillison ML, Maghami E, Spencer S, Pfister DG, Adkins D, Birkeland AC, Brizel DM, Busse PM, Cmelak AJ, et al. NCCN guidelines(R) insights: head and neck cancers, version 1.2022. J Natl Compr Canc Netw. 2022;20(3):224–34.

Article  PubMed  Google Scholar 

Fogliata A, Bolsi A, Cozzi L, Bernier J. Comparative dosimetric evaluation of the simultaneous integrated boost with photon intensity modulation in head and neck cancer patients. Radiother Oncol. 2003;69(3):267–75.

Article  PubMed  Google Scholar 

Dogan N, King S, Emami B, Mohideen N, Mirkovic N, Leybovich LB, Sethi A. Assessment of different IMRT boost delivery methods on target coverage and normal-tissue sparing. Int J Radiat Oncol Biol Phys. 2003;57(5):1480–91.

Article  PubMed  Google Scholar 

Mohan R, Wu Q, Manning M, Schmidt-Ullrich R. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys. 2000;46(3):619–30.

Article  CAS  PubMed  Google Scholar 

Mazeron JJ, Ardiet JM, Haie-Meder C, Kovacs G, Levendag P, Peiffert D, Polo A, Rovirosa A, Strnad V. GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas. Radiother Oncol. 2009;91(2):150–6.

Article  PubMed  Google Scholar 

Mazeron JJ, Noel G, Simon JM. Head and neck brachytherapy. Semin Radiat Oncol. 2002;12(1):95–108.

Article  PubMed  Google Scholar 

Kovacs G, Martinez-Monge R, Budrukkar A, Guinot JL, Johansson B, Strnad V, Skowronek J, Rovirosa A, Siebert FA, Head G-E, et al. GEC-ESTRO ACROP recommendations for head & neck brachytherapy in squamous cell carcinomas: 1st update - Improvement by cross sectional imaging based treatment planning and stepping source technology. Radiother Oncol. 2017;122(2):248–54.

Article  PubMed  Google Scholar 

Crook J, Mazeron JJ, Marinello G, Martin M, Raynal M, Calitchi E, Faraldi M, Ganem G, Le Bourgeois JP, Pierquin B. Combined external irradiation and interstitial implantation for T1 and T2 epidermoid carcinomas of base of tongue: the Creteil experience (1971–1981). Int J Radiat Oncol Biol Phys. 1988;15(1):105–14.

Article  CAS  PubMed  Google Scholar 

Chen J, Pappas L, Moeller JH, Rankin J, Sharma PK, Bentz BG, Fang LC, Hayes JK, Shrieve DC, Hitchcock YJ. Treatment of oropharyngeal squamous cell carcinoma with external beam radiation combined with interstitial brachytherapy. Head Neck. 2007;29(4):362–9.

Article  CAS  PubMed  Google Scholar 

Gibbs IC, Le QT, Shah RD, Terris DJ, Fee WE, Goffinet DR. Long-term outcomes after external beam irradiation and brachytherapy boost for base-of-tongue cancers. Int J Radiat Oncol Biol Phys. 2003;57(2):489–94.

Article  PubMed  Google Scholar 

Chen LA, Anker CJ, Hunt JP, Buchmann LO, Grossmann KF, Boucher K, Fang LM, Shrieve DC, Hitchcock YJ. Clinical outcomes associated with evolving treatment modalities and radiation techniques for base-of-tongue carcinoma: thirty years of institutional experience. Cancer Med. 2015;4(5):651–60.

Article  PubMed  PubMed Central  Google Scholar 

AJCC cancer staging manual. New York, NY: Springer; 2010

Nationellt kvalitetsregister för huvud- och halscancer (SweHNCR) [https://statistik.incanet.se/Huvud-hals/]

Platek ME, Jayaprakash V, Gupta V, Cohan DM, Hicks WL Jr, Winslow TB, Platek AJ, Groman A, Dibaj S, Arshad H, et al. Subsite variation in survival of oropharyngeal squamous cell carcinomas 2004 to 2011. Laryngoscope. 2017;127(5):1087–92.

Article  PubMed  Google Scholar 

Pernot M, Hoffstetter S, Peiffert D, Aletti P, Lapeyre M, Marchal C, Luporsi E, Bey P, Nancy VL. Role of interstitial brachytherapy in oral and oropharyngeal carcinoma: reflection of a series of 1344 patients treated at the time of initial presentation. Otolaryngol Head Neck Surg. 1996;115(6):519–26.

Article  CAS  PubMed  Google Scholar 

LENT Soma tables. Radiother Oncol. 1995;35(1):17–60.

Article  Google Scholar 

Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31(5):1341–6.

Article  CAS  PubMed  Google Scholar 

Beitler JJ, Smith RV, Silver CE, Quish A, Deore SM, Mullokandov E, Fontenla DP, Wadler S, Hayes MK, Vikram B. Close or positive margins after surgical resection for the head and neck cancer patient: the addition of brachytherapy improves local control. Int J Radiat Oncol Biol Phys. 1998;40(2):313–7.

Article  CAS  PubMed  Google Scholar 

Grabenbauer GG, Rödel C, Brunner T, Schulze-Mosgau S, Strnad V, Müller RG, Iro H, Sauer R. Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer the oral cavity and oropharynx. Review of 318 patients treated between 1985 and 1997. Strahlenther Onkol. 2001;177(7):338–44. https://doi.org/10.1007/PL00002416.

Article  CAS  PubMed  Google Scholar 

Melzner WJ, Lotter M, Sauer R, Strnad V. Quality of interstitial PDR-brachytherapy-implants of head-and-neck-cancers: predictive factors for local control and late toxicity? Radiother Oncol. 2007;82(2):167–73.

Article  PubMed  Google Scholar 

Lapeyre M, Hoffstetter S, Peiffert D, Guerif S, Maire F, Dolivet G, Toussaint B, Mundt A, Chassagne JF, Simon C, et al. Postoperative brachytherapy alone for T1–2 N0 squamous cell carcinomas of the oral tongue and floor of mouth with close or positive margins. Int J Radiat Oncol Biol Phys. 2000;48(1):37–42.

Article  CAS  PubMed  Google Scholar 

Takacsi-Nagy Z, Polgar C, Oberna F, Somogyi A, Major T, Remenar E, Fodor J, Kasler M, Nemeth G. Interstitial high-dose-rate brachytherapy in the treatment of base of tongue carcinoma. Strahlenther Onkol. 2004;180(12):768–75.

Article  PubMed  Google Scholar 

Garcia-Consuegra A, Gimeno Morales M, Cambeiro M, Tagliaferri L, Kovacs G, Van Limbergen E, Ramos LI, Manuel Arnaiz J, Alcalde J, Lecanda F, et al. Dose volume histogram constraints in patients with head and neck cancer treated with surgery and adjuvant HDR brachytherapy: a proposal of the head and neck and skin GEC ESTRO Working group. Radiother Oncol. 2021;154:128–34.

Article  CAS  PubMed  Google Scholar 

Nabil S, Samman N. Incidence and prevention of osteoradionecrosis after dental extraction in irradiated patients: a systematic review. Int J Oral Maxillofac Surg. 2011;40(3):229–43.

Article  CAS  PubMed  Google Scholar 

Reuther T, Schuster T, Mende U, Kubler A. Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients–a report of a thirty year retrospective review. Int J Oral Maxillofac Surg. 2003;32(3):289–95.

Article  CAS  PubMed  Google Scholar 

Frankart AJ, Frankart MJ, Cervenka B, Tang AL, Krishnan DG, Takiar V. Osteoradionecrosis: exposing the evidence not the bone. Int J Radiat Oncol Biol Phys. 2021;109(5):1206–18.

Article  PubMed  Google Scholar 

Toneatti DJ, Graf RR, Burkhard JP, Schaller B. Survival of dental implants and occurrence of osteoradionecrosis in irradiated head and neck cancer patients: a systematic review and meta-analysis. Clin Oral Investig. 2021;25(10):5579–93.

Article  PubMed  PubMed Central  Google Scholar 

Al-Mamgani A, Levendag PC, van Rooij P, Meeuwis CA, Sewnaik A, Teguh DN. Intensity-modulated radiotherapy followed by a brachytherapy boost for oropharyngeal cancer. Head Neck. 2013;35(12):1689–97.

Article  PubMed  Google Scholar 

Olteanu LAM, Duprez F, De Neve W, Berwouts D, Vercauteren T, Bauters W, Deron P, Huvenne W, Bonte K, Goethals I, et al. Late mucosal ulcers in dose-escalated adaptive dose-painting treatments for head-and-neck cancer. Acta Oncol. 2018;57(2):262–8.

Article  PubMed